Shuttle pharmaceuticals inc stock
WebShuttle Pharmaceuticals Holdings Inc Stock. Add to Watchlist. Overview. Earnings Dividend Ownership. $1.39-0.06 (-4.14%) Updated Apr 6, 2024. ... Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. WebCompany profile page for Shuttle Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information
Shuttle pharmaceuticals inc stock
Did you know?
WebGet the latest Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock news and headlines to help you in your trading and investing decisions. WebApr 6, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (SHPH) NASDAQ: SHPH · IEX Real-Time Price · USD. Add to Watchlist 1.39-0.06 (-4.14%) At close: Apr 6, 2024, 4:00 PM. 1.38 ... No financial forecasts available for this stock Revenue Forecast. No data available. Revenue Growth. No data available. EPS Forecast. No data available.
WebThe Company was originally founded as Shuttle Pharmaceuticals, LLC in December 2012 in the State of Maryland. In June 2024, Shuttle Pharmaceuticals, Inc. became a wholly owned subsidiary of Shuttle Pharmaceuticals Holdings, Inc., a State of Delaware corporation. WebFind real-time SHPH - Shuttle Pharmaceuticals Holdings Inc stock quotes, company profile, news and forecasts from CNN Business.
WebApr 7, 2024 · Shuttle Pharmaceuticals Holdings Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. There are not analysts providing consensus earnings estimates for the current fiscal year. Shuttle Pharmaceuticals Holdings Inc does not currently pay a dividend. WebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
WebSep 6, 2024 · PR Newswire. ROCKVILLE, Md., Sept. 6, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on ...
WebShuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate Update. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update in connection with … black wing doveWebDec 29, 2024 · Shuttle Pharmaceuticals Holdings (NASDAQ: SHPH) is owned by 0.98% institutional shareholders, 72.32% Shuttle Pharmaceuticals Holdings insiders, and 26.70% retail investors. Anatoly Dritschilo is the largest individual Shuttle Pharmaceuticals Holdings shareholder, owning 7.49M shares representing 54.88% of the company. foxtel tv packages and pricesWeb2 days ago · Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and … foxtel tune free to airWebMar 30, 2024 · Detailed statistics for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock, including valuation metrics, financial numbers, share information and more. black wing dragonflyWebMar 11, 2024 · Complete Shuttle Pharmaceuticals Holdings Inc. stock information by Barron's. View real-time SHPH stock price and news, along with industry-best analysis. black wing dressWeb1 day ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) blackwing dragon t s joyceWebAug-30-22 04:40PM. Shuttle Pharmaceuticals Announces Pricing of Initial Public Offering. PR Newswire. Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. blackwing ec01